-
Shedding Light on HDL: Myths and Controversies
CME Join Drs Nicholls, Ballantyne and Davidson as they discuss HDL and the latest clinical research in residual CV risk reduction.
Medscape Education Cardiology, May 2012
-
MiRNAs and Diabetes Mellitus
CME How might microRNAs be used to diagnose and treat diabetes? The current review highlights the state of the art of this subject.
Expert Review of Endocrinology and Metabolism, May 2012
-
Lowering LDL-Cholesterol and Novel Targets to Achieve New Levels
CME Beyond statins: genetic mutations show the way. 'How low can we go' takes on a new dimension.
Medscape Education Cardiology, April 2012
-
Statins Before Cardiac Surgery May Improve Some Clinical Outcomes
CME Statins given before cardiac surgery significantly reduced the risk for postoperative atrial fibrillation and significantly shortened the length of stay in the intensive care unit.
Heartwire CME, April 2012
-
Personalizing Lipid Management: Metabolism Matters -- Strategies to Increase Statin Adherence
CME Drs Underberg, Brown, and Fazio discuss the potential for drug-drug interactions in patients on statin therapy and their impact on adherence.
Medscape Education Cardiology, April 2012
-
Reducing Cardiovascular Risk in Patients With Diabetes: Focus on Multiple Therapeutic Targets
CME Join Drs Lincoff and McGuire as they discuss PPAR-alpha and -gamma agonists and their role in cardiovascular risk reduction.
Medscape Education Cardiology, April 2012
-
The Promise of Adipose-Derived Regenerative Cells in Cardiovascular Medicine
CME Dr Miller discusses the rationale, utility, and potential role of cell-based therapy in cardiovascular disease with experts in the field.
Medscape Education Cardiology, April 2012
-
The Role of CETP in Reverse Cholesterol Transport: Will Its Inhibition Reverse Atherosclerosis?
CME Join Drs Ansell and Nicholls as they discuss the latest clinical evidence on CETP inhibition and its impact on HDL-C and atherosclerosis.
Medscape Education, March 2012
-
Personalizing Lipid Management: Complex Cases in Polypharmacy
CME Polypharmacy increases the risk of drug-drug interactions when statin therapy is initiated. Take this case-based survey on statin selection.
Medscape Education Cardiology, March 2012
-
HDL as a Protective Lipoprotein: Focus on Coronary Artery Disease
CME Join Drs Barter and Rader as they discuss HDL's role in atherogenic disease and the factors that influence the functionality of HDL.
Medscape Education Cardiology, March 2012
-
A Patient-Centered Approach to Exploring the Gastrointestinal Issues of Antiplatelet Therapy
CME/CE Watch a patient case simulation, and hear Dr Cryer's advice for assessing gastrointestinal risk in patients on antiplatelet therapy.
Medscape Education Cardiology, March 2012
-
HDL in Motion: Molecular Dynamics & Disease Pathophysiology
CME Join Dr Arnold von Eckardstein for an in depth view of the dynamic relationship between HDL and LDL particles and lipid homeostasis.
Medscape Education Cardiology, March 2012
-
FDA Safety Changes: Risks Linked With Statins and HIV/HCV Protease Inhibitors
CME/CE The US Food and Drug Administration is revising the labels of certain statins as well as protease inhibitors for HIV and hepatitis C virus to warn about interactions between the 2 sets of drugs.
Medscape Education Clinical Briefs, March 2012
-
Younger Women With MI Less Likely to Have Chest Pain
CME/CE New data show that younger women with a myocardial infarction are more likely to present without chest pain than older women or men and have the highest risk for death of any group.
Heartwire CME, March 2012
-
Timing is Everything: 24-Hour Control of Blood Pressure
CME Controlling hypertension is easy right? Not so fast. Dr William Cushman presents insights and tips on how to get patients to goal in “Timing Is Everything: 24-hour Control of Blood Pressure.”
Medscape Education Cardiology, March 2012
-
The Complex Type 2 Diabetes Patient: Improving Performance, Improving Care
CME How can performance measures and guidelines help guide the treatment of complex patients with type 2 diabetes?
Medscape Education Diabetes & Endocrinology, February 2012
-
Continuity of Care in ACS: Application of Treatment Guidelines From the Acute to the Community Setting
CME/CE Review guidelines in ACS treatment, including P2Y12 receptor antagonists, lipid management, weight management, and physical activity.
February 2012
-
Optimizing the Management of Patients With Acromegaly
CME Dr Anne Klibanski and colleagues discuss how multimodal therapy delivered by a multidisciplinary team can treat patients with acromegaly.
Medscape Education Diabetes & Endocrinology, February 2012
-
Dyslipidemia and Residual Atherosclerotic Risk: Focus on HDL-C
CME Clarify emerging therapeutic options for treating patients with low HDL levels based on data from recent pivotal clinical trials
February 2012
-
Fellows’ Corner: Residual Cardiovascular Risk and HDL – The Year in Review
CME Join Dr Nidhi Mehta as she reviews the results of this year’s major trials aimed at reducing cardiovascular risk and raising HDL-C.
Medscape Education Cardiology, February 2012
